Nutraceuticals

  • Once daily dose Curcumin formulation

  • Based on Patented Aqueosome® technology

  • First innovative herbal formulation for eye health

  • Proven efficacy in Retinal pigment epithelial & HUVEC cells 

  • World’s first Ginger product with > 26% Total Gingeroids

  • Supports healthy sexual performance

  • Supports healthy testosterone levels

Total Turmeric

Once daily dose: 500 mg
  • World’s first formulation from whole turmeric extract (>20% total Curcuminoids)

  • 113x bioavailable for free Curcumin

  • 51% reduction in total WOMAC score of knee osteoarthritis 

  • Based on Patented Aqueosome® technology

 

Bioavailability Studies

A. Animal Study

Animal BA study to compare the oral bioavailability of Turmeric T5 complex™ and standard curcumin (95%)

In comparative bioavailability study, Turmeric T5 complex™  was found to be superior to the standard curcumin (95%)  and leading Curcumin formulation.

Turmeric T5                 C-95%                      CVP-01

B. Brain Transport Study

Turmeric T5 complex™ delivers curcumin into brain-Animal Study

Confocal 3 D image of brain section from rat supplemented with Turmeric T5 complex™  
(Green Fluorescence confirms the presence of curcumin)
C. Human Study

Human BA study to compare the oral bioavailability of Turmeric T5 complex™ and standard curcumin (95%)

TurmericT5  showed 113x higher relative bioavailability than standard 
Curcuminoids (95%)

Turmeric T5                CP-01                   C-95

Human Clinical Efficacy Studies

In a human clinical efficacy study (n=50), single dose of TurmericT5  reduced joint pain, stiffness and improved Physical functioning significantly in Osteoarthritis Patients as assessed by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score. This study also confirmed the long-term safety of TurmericT5 .

Safety Studies

TurmericT5  is evaluated for safety through animal and human studies.

1. Animal Safety Study:
   Acute oral toxicity study conducted as per OECD guidelines: LD50 was found to be >5000 mg/Kg BW


2. Human Safety studies:
    Safety was evaluated through three human clinical studies: Product was found to be safe

  • World’s first Ginger product with > 26%
    Total Gingeroids

  • Soluble and Sustained release

  • Reduced dose

  • Based on Patented Aqueosome® technology

 
 
  • First innovative herbal formulation for eye health in people with age-related macular changes (AMD)

  • Works in synergy with Biologics

  • Proven efficacy in Retinal pigment epithelial cells (Ex vivo study)

  • Non-vitamin herbal formulation

  • Patented

Eye Health

WET AMD: Pathophysiology

VEGF (Vascular Endothelial Growth Factor) & PDGF

(Platelet Derived Growth Factor) are the major potent
stimulators of wet AMD

Mechanism of Action
  • VEGF down-regulating activity

  • VEGF binding activity

  • PDGF downregulating activity

  • Angiogenesis inhibitory activity

Efficacy Proven for
  • VEGF down-regulating activity in ARPE cell lines (Human Retinal Pigment Epithelial Cell lines)

  • VEGF binding activity

  • Inhibition of formation of new blood vessels in HUVEC (Human Umbilical Vein Endothelial Cells)

1. VEGF downregulating activity
in ARPE Cells
2. VEGF binding activity
in ARPE cells
3.  Angiogenesis inhibitory activity

Inhibition of formation of new blood vessels in HUVEC cells
in comparison with control

 

Sexual Wellbeing

  • Supports healthy sexual performance

  • Supports healthy testosterone levels

  • Clinically proven – Human Clinical Study

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.’

  •  Aged Black Garlic Extract

  • Standardized to 0.24% S-Allyl Cysteine (SAC)

  • Cardiovascular, Immune and Gut Protection